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Although many epidemiological studies have shown that obesity
increases the risk of renal cell cancer among women, the evidence
for men is considered weaker (Wolk et al, 1996; McLaughlin and
Lipworth, 2000).
The incidence of renal cell cancer, the predominant type of
kidney cancer, has been increasing both in the US (Chow et al,
1999) and in most Western countries (Black et al, 1997; Liu et al,
1997). Today, renal cell cancer accounts for about 2% of cancers in
the US (Landis et al, 1999), as well as worldwide (Parkin, 1998),
with 30 000 cases occurring in the US in 1999 (Landis et al, 1999).
The incidence varies more than 10-fold over the world. The
highest rates are found in North America and Europe and the
lowest in Asia (Parkin, 1998). Renal cell cancer occurs about
twice as often among men, as among women. 
Obesity has also been increasing throughout the world. More
than half of the adult US population is considered to have an
excess weight (body mass index, BMI ≥ 25.0 kg m–2) and nearly
one quarter are clinically obese (BMI ≥ 30.0 kg m–2) (Flegal et al,
1998). The increasing prevalence of obesity might therefore, at
least partly, explain the increasing incidence of renal cell cancer. 
The purpose of this review was to evaluate the existing evidence
that obesity increases the risk of renal cell cancer among both men
and women. We conducted a quantitative summary analysis to
estimate the magnitude of the association taking into account sex
and different study characteristics, such as study design and size.
We also investigated the possible effect modification between
obesity and these factors. 
MATERIALS AND METHODS 
Literature review 
We identified studies investigating the relation between obesity and
kidney cancer, available in MEDLINE 1966 through 1998. We used
the MeSH-terms ‘kidney neoplasms’ plus ‘obesity’, ‘body weight’
or ‘body mass index’ and selected original epidemiological studies.
Additional studies were identified from systematical examinations
of the list of references in the identified articles and previous
reviews (Wolk et al, 1996; McLaughlin and Lipworth, 2000). 
Inclusion criteria 
In adults, cancer of the kidney is classified as either cancer of the
parenchyma (renal cell) or the renal pelvis. In many descriptive
and some analytic studies tumours of the renal parenchyma and
the renal pelvis are combined and the term kidney cancer is used.
Since renal cell cancer is the predominant type, responsible for
more than 80% of all adult kidney neoplasms (Devesa et al, 1990),
studies unable to disentangle the 2 entities were included in our
review. 
In total, we identified 30 studies on obesity and renal cell cancer
risk published between 1966 and 1998 for our review. Each study-
base was eligible only once. When multiple reports were available for
the same study-base we chose the one analysing incident renal cell
cancer as outcome, and/or defining obesity in terms of body mass
index (BMI, kg m–2) and in more detail and/or with  the greater
number of cases. We excluded 6 studies (Whittemore et al, 1985;
Lindblad et al, 1994; Mellemgaard et al, 1994; Moller et al, 1994;
Muscat et al, 1995; Boeing et al, 1997) due to overlapping reports. 
Our quantitative summary analysis was limited to studies
presenting category limits of BMI and relative risk estimates with
their 95% confidence interval (CI), or other results making it
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possible to compute these values. We excluded 9 studies (Wynder
et al, 1974; Lew and Garfinkel, 1979; Whittemore et al, 1984; Yu
et al, 1986; Kadamani et al, 1989; Maclure and Willett, 1990;
Mellemgaard et al, 1991; Partanen et al, 1991; Finkle et al, 1993)
since they did not assess obesity in a comparable way, or present
their results in sufficient detail. 
Data extraction and unification 
For each study we extracted the main characteristics of the study,
the definition of exposure and the relative risk estimates (rate
ratios, odds ratios, hereafter denoted as relative risk, RR), and their
confidence intervals. All information was extracted separately for
men and women. For one study, the results were not presented
separately for men and women, but since crude sex-specific relative
risks could be computed from the results presented in the article the
study was included in the summary analysis (Talamini et al, 1990). 
If the risk of renal cell cancer was expressed in more than one
way, the estimate reflecting greatest degree of controlling for
confounders was used. We considered age and smoking to be the
most important confounding factors in the relation between obesity
and renal cell cancer. We therefore grouped studies as adjusted and
unadjusted depending on if they had controlled for these 2 factors. 
The studies were classified as cohort or case–control, and the
latter were further divided into population-based and hospital-
based. Nested case–control studies, where prospectively gathered
information was analysed in a case–control design, were classified
as cohort studies. 
The category limits in studies assessing BMI as lb ft–2
(McLaughlin et al, 1984; Asal et al, 1988) or kg cm–2 (Kreiger 
et al, 1993) were recalculated to kg m–2. For studies assessing
female obesity as kg m–1.5(McCredie and Stewart, 1992; Mellemgaard 
et al, 1995; Chow et al, 1996) we performed an approximate recal-
culation of these estimates to kg m–2 by dividing the provided esti-
mate with the square root of height. The height was set to 1.64 m,
the mean height of women in recent cohort studies in Northern
America, the Netherlands and Sweden (Smith-Warner et al,
submitted). 
Statistical analysis 
We first estimated the relative risk associated with a unit increase
in BMI (1 kg m–2) for each individual study. The odds ratio was
used as a measure of the relative risk for case–control studies, and
the relative risk estimates were log-transformed. When results
were reported in categories of BMI, these were transformed to an
estimate per unit increase in BMI. To treat BMI as a continuous
exposure variable, its value was set at the midpoint of each cate-
gory. For open-ended categories the approximate midpoint was set
at double the distance between the midpoint and upper bound of
the closest category. The log relative risk, as well as the BMI, for
the reference category was set to zero (corresponding to a relative
risk of 1). We subtracted the midpoint BMI of this category from
the midpoint BMI of all other categories. A weighted regression
was then fit through the origin where the exposure was at the refer-
ence level with log relative risk zero. The regression was weighted
by the inverse variance of the log relative risk for each category.
The correlation between categories was estimated using a previous
method  (Greenland and Longnecker, 1992). 
We used a mixed effects weighted regression model to combine
estimates from BMI categories from the individual studies.
Between-study variation was modelled as a random effect, and
heterogeneity over studies was assessed by the significance of the
between-study variance (Berkey et al, 1995; Takkouche et al,
1999). The within-study variance was taken to be the estimated
variance of the log relative risks for each study, giving more
precise estimates greater weights in the summary measure
(Greenland, 1998). Since each study contributed more than one
relative risk estimate (from different BMI categories), this was a
covariance matrix of dimension equal to the number of categories
minus the reference. For the summary measure, we thus estimated
the effect of BMI under the random-effects model while
accounting for within-study correlation. To examine whether the
mean of the random coefficients for BMI was the same for
different groups defined by study characteristics (e.g., males
versus females, US studies versus non-US studies), models
including interaction term(s) between BMI and the study charac-
teristics were further fitted and the significance of the interaction
term(s) tested. The PROC MIXED procedure in SAS was applied
in our analysis (SAS Institute, 1996) with the parms option
allowing the input of known within-study variances. To examine
whether a curvilinear model fits the data better than the linear, we
added a quadratic term for BMI to the model. 
Potential influence that unpublished data could have on our
summary analysis was examined using a distortion analysis
(Rosenthal, 1979). It was assumed that some studies had data on
BMI and renal cell cancer risk but that the results were not
published because they were not significant. To be conservative, it
was assumed that the association between BMI and renal cell
carcinoma in these studies was inverse. An average relative risk of
0.85 (95% confidence interval 0.67–1.08) associated with each
unit increase in BMI was used. Confidence intervals including 1.0
were chosen, assuming that reports with significant associations
would probably have been published. 
Population attributable risk percent for renal cell cancer was
estimated for persons with excess weight (BMI ≥ 25 kg m–2)
compared to those of normal weight (BMI 20–24.9 kg m–2). We
calculated the population attributable risk percent as: 
pe (RR–1)  100
pe (RR–1) +1
where pe represents the prevalence in the population and RR repre-
sents the relative risk (Cole and MacMahon, 1971). Prevalence
data were obtained from a national US survey that assessed the
prevalence of excess weight in categories of overweight (BMI
25–29.9 kg m–2), class I obesity (BMI 30–34.9 kg m–2), class II
obesity (BMI 35–39.9 kg m–2), or class III obesity (BMI ≥ 40 kg
m–2) (Flegal et al, 1998). In this survey, 39.4% among the men
were overweight, 14.6% had class I obesity, 3.6% had class II
obesity, and 1.8% had class III obesity. Among women, 24.7%
were overweight, 14.2% had class I obesity, 6.8% had class II
obesity, and 3.9% had class III obesity. The population attributable
risk percent was calculated for each category of excess weight,
using the relative risk from the summary analysis, and thereafter
summarized separately for each sex. 
RESULTS 
Qualitative review of the literature 
In total, 24 studies on obesity and renal cell cancer with unique
study bases, published between 1966 and 1998 were identified for
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this review. Of these, 22 presented results for men and equally
many for women. The individual studies are summarized in
Appendix 1. 
The majority of the included studies were population-based
case–control studies based on incident cases of renal cell cancer,
and assessed obesity as BMI or equivalent. About a third of the
studies adjusted for confounding by age and smoking. In most
studies the majority of the case subjects were 50 years and older,
but Yu and co-workers (1986) limited their study to younger cases
(15–59 years old) and in the study by Hiatt and co-workers (1994)
the mean age was 50.7 years among case subjects. 
An increased risk of renal cell cancer among obese men was
supported by all but 2 studies. Wynder and co-workers (1974)
found no effect of obesity among men, while a decreased risk was
indicated in the study by Talamini and co-workers (1990). Among
women, all but one study supported a positive association between
obesity and renal cell cancer. In contrast, a decreased risk was indi-
cated in the study by Talamini and co-workers (1990). 
Quantitative summary analysis 
The quantitative summary analysis was based on 14 studies on
each sex. The relative risks and their 95% confidence intervals for
BMI as a continuous variable in studies on men are shown in
Figure 1, together with the summary estimate based on a random
effects model. Of the 14 studies included in the summary analysis,
all but one (Talamini et al, 1990) indicated a positive association
with obesity, significant in all but 4 studies (McLaughlin et al,
1992; Kreiger et al, 1993; Hiatt et al, 1994; Chow et al, 1996). The
summary relative risk for all male studies combined with a random
effect model was 1.07 (95% CI 1.04–1.09) per unit of increase in
BMI (1 kg m–2) (Table 1). There was some heterogeneity across
studies (P value for between-study variance = 0.08). 
The point estimates and their 95% confidence intervals for BMI
as a continuous variable in studies on women are shown in Figure 2.
Only one of the 14 studies included in the summary analysis showed
no association between BMI and risk of renal cell cancer (Talamini
et al, 1990), while all the others indicated an increased risk among
obese women. This positive association was significant in half of the
studies (McLaughlin et al, 1984; Kreiger et al, 1993; Mellemgaard
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Figure 1 Results of the reanalyses and summary analysis of published
studies on the association between body mass index (BMI) and renal cell
cancer risk among men. Relative risk per unit of increase in BMI (1 kg m–2)
and 95% confidence intervals (CI) 
Table 1 Results of summary analysis. Relative risk (RR) of renal cell cancer per unit of increase of BMI (1 kg m–2) and 95% confidence intervals (CI) 
Group of studies No. of studies RR 95% CI Test of heterogeneity (P value) Test of effect modificationa (P value) 
All studies 28 1.07 1.05–1.09 0.03 
Sex 
Men 14 1.07 1.04–1.09 0.08 
Women 14 1.07 1.05–1.09 0.24 0.77 
Study design 
Cohort 6 1.07 1.04–1.09 0.69b
Population-based case – control 16 1.08 1.06–1.10 0.23 
Hospital-based case – control 6 1.04 1.00–1.10 0.23 0.16 
Case status 
Studies with incident cases 24 1.07 1.05–1.09 0.03 
Studies with prevalent cases 2 1.06 1.02–1.10 0.39b
Studies with dead cases 2 1.07 1.04–1.10 0.52b 0.99 
Study size 
Smallc 12 1.05 1.02–1.09 0.14 
Largec 16 1.08 1.06–1.09 0.26 0.14 
Study location 
The US 16 1.08 1.06–1.10 0.27 
Countries other than the US 12 1.06 1.03–1.09 0.11 0.24 
Adjusted for smoking 
Yes 14 1.08 1.06–1.10 0.49b
No 14 1.06 1.03–1.09 0.06 0.32 
aPossible effect modification was tested between BMI and sex, study design, case status, study size, study location, and adjustment for smoking. 
bFrom fixed effect model, as within-study variance was larger than between-study variance, P value under mixed-effect model was 1.0. 
cAmong men: Small = studies with less than 200 cases; large = studies with 200 or more cases. Among women: Small = studies with less than 100 cases; 
large = studies with 100 or more cases. 
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et al, 1995; Chow et al, 1996; Health et al, 1997; Prineas et al, 1997;
Yuan et al, 1998). When all studies on women were combined, the
summary estimate with a random effect model was 1.07 (95% CI
1.05–1.09) per unit of increase in BMI (Table 1). There was no
significant between-study variance (P = 0.24). 
The summary relative risk for men and women together was
1.07 (95% CI 1.05–1.09) per unit of increase in BMI (Table 1).
One unit of increase in BMI corresponds to 3.1 kg for a man of an
average height (1.77 m) and to 2.7 kg for a woman (1.64 m).
When combining all studies the test for heterogeneity became
statistical significant (P = 0.03). 
We have examined whether a curvilinear model improves the fit
by adding a quadratic term for BMI to the model. The quadratic
term was not statistically significant in the analysis for males (P =
0.13), for females (P = 0.60), nor for all studies together (P = 0.45).
We hypothesized that sex, study design, case status, study size,
study location or degree of adjustment for confounding might
explain inter-study variability in results. However, positive associ-
ations of comparable strengths were present in all subsets of
studies, regardless of study design, study size, study location
(studies from the US vs. studies from other countries) or degree 
of adjustment for confounding (studies not adjusted for smoking
vs. studies adjusted for smoking) (Table 1). For most subsets 
of studies, the stratum-specific between-study variance became non-
significant, indicating no significant heterogeneity between 
the studies in these subgroups. Significant heterogeneity 
between studies was found only for studies with incident cases.
However, some between-study variance was found for studies on
men and studies not adjusted for smoking (Table 1). Furthermore,
we found no effect modification between BMI and sex, study loca-
tion, study design or study size, respectively (Table 1). 
The potential influence that unpublished data could have on our
summary analysis was examined. The distortion (‘file drawer’)
analysis (Rosenthal, 1979) showed that if we could find 47 or
more unpublished studies showing an inverse association between
BMI and renal cell carcinoma, the hypothetical pooled estimate of
the relative risk would no longer be significant. This indicates that
our summary risk estimate is robust, and is not sensitive to poten-
tial publication bias. 
The population attributable risk percent for excess weight was
calculated using the prevalence in the US (Flegal et al, 1998), and
the obtained relative risk of 1.07 per 1 kg m–2 increase in BMI
(corresponding to a relative risk of 1.35 for overweight subjects,
1.70 for subjects with class I obesity, 2.05 for subjects with class II
obesity, and 2.40 for subjects with class III obesity compared to
subjects with normal weight). We estimated that 27% of the renal
cell cancer cases among American men and 29% among women
could be related to overweight and obesity (BMI > 25 kg m–2). 
DISCUSSION 
In contrast to what is generally described in qualitative reviews,
our quantitative summary analysis showed that the association
between obesity, assessed as increased BMI, and risk of renal cell
cancer was equally strong among men and women. The differ-
ences in strength of association observed across the individual
studies, could not be explained by either sex, study design, case
status, study size, study location or degree of adjustment for
confounding. 
The discrepancy between our results and previous findings,
reporting stronger association among women, could be explained
by the differences in distribution of BMI among men and women.
Although an equal amount of men and women is overweight and
obese, women tend to be more obese. In the US, where 59.4% of
the men and 49.6% of the women have a BMI of 25 kg m–2 or
more, 39.4% of the men are overweight (BMI 25–29.9 kg m–2) and
20% obese (BMI > 30 kg m–2), while 24.7% of the women are
overweight and 24.9% are obese (Flegal et al, 1998). Therefore,
the highest BMI quartile for women usually consists of more
obese individuals than the highest quartile for men, resulting in a
higher observed relative risk. 
The strengths of our review include the large number of
included studies and, more important, the quantitative summary
analysis comparing the relative risk of renal cell cancer is based on
the same increase in BMI for both men and women. 
The main limitation of our summary analysis concerns the
possibility that the included studies are a biased sample of studies
in general, since small studies and studies finding no association
are more likely to be unpublished (Greenland, 1998). However, in
our stratified summary analysis, we observed positive association
of comparable strengths among small and large studies. Another
concern is that not all published studies provided results that could
be included in the summary analysis. In our analysis, 9 of the iden-
tified studies (Wynder et al, 1974; Lew and Garfinkel, 1979;
Whittemore et al, 1984; Yu et al, 1986; Kadamani et al, 1989;
Maclure and Willett, 1990; Partanen et al, 1991; Mellemgaard
et al, 1991; Finkle et al, 1993) could not be included due to insuf-
ficient presented data. However, this is not likely to bias the
observed association, since all but one of these studies (Wynder
et al, 1974) indicated an increased risk of renal cell cancer among
obese persons. The distortion analysis, used to evaluate the sensi-
tivity of our estimates to publication bias, indicated that a large
number of non-significant unpublished studies would be necessary
to nullify the summary results. 
Another potential limitation of our findings is that the majority
of the studies in the summary analysis used retrospective 
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Figure 2 Results of the reanalyses and summary analysis of published
studies on the association between body mass index (BMI) and renal cell
cancer risk among women. Relative risk per unit of increase in BMI (1 kg m-2)
and 95% confidence intervals (CI) 
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self-reports of weight and height. Although such data have been
shown to be quite accurate, obese subjects in general under-report
their weight more than non-obese subjects while underweight
subjects overestimate their body size (Kuskowska-Wolk et al,
1989). This might lead to nondifferential misclassification which,
if anything, only underestimates the true association between
obesity and renal cell cancer and therefore can not explain our
finding of a positive association (Rothman and Greenland, 1998).
We can not exclude the possibility of differential misclassification
(recall bias) in the retrospective case–control studies (i.e. case
subjects might report their weight differently than control
subjects), but the consistency of findings from the case–control
studies and the prospective cohort studies is a strong argument
against recall bias. 
The studies included in the summary analysis controlled for a
varying degree of confounders. We considered age and smoking to
be the most important confounders. All studies adjusted for age.
Studies controlling also for smoking revealed a slightly higher
summary relative risk than other studies. Since cigarette smoking
is consistently associated with an increased risk of renal cell
cancer (McLaughlin et al, 1995a) as well as with lower body
weight (Williamson et al, 1991) this effect is expected. Although
hypertension and diabetes (McLaughlin et al, 1995b; Schlehofer 
et al, 1996; Yuan et al, 1998; Lindblad et al, 1999) are possible
confounders of the association between obesity and renal cell
cancer, only 3 studies among men (Hiatt et al, 1994; Chow et al,
1996; Gamble et al, 1996) and 2 studies among women (Hiatt et al,
1994; Chow et al, 1996) adjusted for hypertension and none
adjusted for diabetes. However, since both diabetes and hyperten-
sion could be intermediate steps in the causal pathway, it is not
clear if adjustment is desirable. 
Obesity might be associated with increased risk of renal cell
cancer through several hormonal mechanisms. Increasing BMI is
accompanied by elevated levels of fasting serum and free insulin-
like growth factor-I (IGF-I) among both men and women (Frystyk
et al, 1995). Insulin and IGF-I could both contribute to the growth
and proliferation of renal cell cancer (Kellerer et al, 1995).
Epidemiological studies indicate that patients with diabetes, which
is associated with higher plasma insulin levels, have an increased
risk of renal cell cancer (Schlehofer et al, 1996; Lindblad et al,
1999). Furthermore, diabetes and/or hypertension, both associated
with obesity (Kopelman, 2000), might be intermediate steps in the
causal pathway between obesity and renal cell cancer. Obesity also
affects the hormonal milieu by increasing levels of free endoge-
nous oestrogen (Zumoff, 1988) that may affect renal cell prolifera-
tion and growth by direct endocrine receptor-mediated effects, by
regulation of receptor concentrations or through paracrine growth
factors. However, though potent oestrogens have been shown to
induce renal tumours in animal models (Stadler and Vogelzang,
1993), there is little epidemiological evidence supporting an asso-
ciation of exogenous oestrogens in humans (McLaughlin and
Lipworth, 2000). Obesity could also have other effects on the
kidneys. Obese individuals have been reported to have higher
glomerular filtration rate and renal plasma flow independent of
hypertension, which may increase risk for kidney damage (Hall 
et al, 1994; Ribstein et al, 1995), and therefore make the kidney
more susceptible to carcinogens. 
To summarize, excess body weight was positively associated
with risk of renal cell cancer, equally strongly among both men
and women. This finding is of great public health relevance, since
it suggests that renal cell cancer can be prevented if a healthy body
weight is maintained lifelong. According to our estimates, 27% of
the renal-cell cancer cases among American men, and 29% among
women could be attributed to overweight and obesity. This corre-
sponds to more than 8000 cases yearly in the US and is compa-
rable to a previous estimation (Benichou et al, 1998). Maintaining
a healthy body weight can therefore be an effective strategy to
prevent renal cell cancer. 
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Appendix 1 Summary of published studies of obesity and risk of renal cell cancera
First author, year of publication Type of studyb Country Number of casesc Exposured Categoriese RR 95% CI 
Wynder, 1974 CCH USA 129 M RBW1 No association ––  
73 F P<0.005 for RBW 125+ ––  
Lew, 1979 Coh USA Unknown RBW2 M: 130–139 vs 90–109 1.51 – 
F: 140+ vs <80 2.03 – 
McLaughlin, 1984 CCP USA 313 M BMI >28.0 vs ≤ 23.6 1.5 1.0–2.4 
182 F >26.2 vs ≤ 21.6 2.1 1.2–3.9 
Whittemore, 1984 Coh USA 77 M Weight (lb) 180+ vs <140 2.5 0.9–6.8 
Goodman, 1986 CCH USA 189 M BMI 28+ vs <24 2.67 1.49–5.94 
78 F 28+ vs <24 2.38 1.15–6.85 
Yu, 1986 CCP USA 109 M BMI Highest vs lowest quartile 1.8 0.8–4.0 
51 F Highest vs lowest quartile 2.7 0.8–9.3 
Asal, 1988 CCP USA 209 M BMI >29.4 vs <23.8 3.3 1.8–6.1 
106 F >30.1 vs <22.5 11.2 0.6–2.6 
Kadamani, 1989f CCP USA 142 M % standard 140+ vs <120 3.8 – 
68 F BMI 140+ vs <120 3.0 – 
Maclure, 1990g CCP USA 135 M BMI >28 vs ≤ 28 1.7 0.9–3.2 
68 F >28 vs ≤ 28 1.7 1.1–2.8 
Talamini, 1990 CCH Italy 150 M+90 F BMI >27 vs <24 0.74 0.51–1.07 
Mellemgaard, 1991 Coh Denmark 25 M Obesity 1.52 0.05>P>0.001 
69 F 2.67 2.08–3.38 
Partanen, 1991 CCP Finland 338 M+F Obesity 1.2 0.9–1.7 
McCredie, 1992 CCP Australia 310 M BMI >25.34 vs <23.05 1.6 1.1–2.5 
179 F kg/m1.5 >30.79 vs <27.21 1.3 0.8–2.1 
McLaughlin, 1992h CCP China 90 M BMI >23.3 vs ≤ 19.7 1.7 0.5–5.7 
64 F >30.6 vs ≤ 24.4 3.3 0.7–15.1 
Benhamou, 1993 CCH France 138 M BMI ≥ 27 vs ≤ 20 2.4 1.0–5.9 
58 F ≥ 27 vs ≤ 20 3.5 1.0–11.8 
Finkle, 1993 Coh USA 191 F kg/m1.5 Highest vs lowest quartile 2.6 1.4–4.8 
Krieger, 1993 CCP Canada 282 M BMI >25.1 vs ≤ 21.5 1.3 0.8–2.2 
181 F >23.0 vs ≤ 19.7 2.5 1.4–4.6 
Hiatt, 1994 Coh USA 167 M BMI ≥ 28.3 vs <24.6 1.4 0.7–3.1 
90 F ≥ 27.8 vs <21.8 1.2 0.4–4.3 
Mellemgaard, 1995 CCP International 1050 M BMI ≥ 26.6 vs <23.1 1.6 1.3–2.1 
682 F kg/m1.5 ≥ 32.7 vs <27.3 2.0 1.5–2.7 
Chow, 1996 CCP USA 274 M BMI ≥ 29.75 vs ≤ 23.13 1.3 0.7–2.3 
163 F kg/m1.5 ≥ 36.57 vs ≤ 26.75 3.8 1.7–8.4 
Gamble, 1996 Coh USA 37 M BMI ≤ 25 vs <21 3.29 0.93–11.62 
Heath, 1997 Coh USA 212 M BMI ≥ 31.1 vs 20.7–24.6 1.6 0.9–2.7 
123 F ≥ 32.3 vs 19.1–21.9 3.1 1.5–6.4 
Prineas, 1997 Coh USA 62 F BMI >28.3 vs <24.3 2.77 1.34–5.70 
Yuan, 1998 CCP USA 781 M BMI ≥ 30 vs <22 4.6 2.9–7.5 
423 F ≥ 30 vs <22 4.0 2.3–7.0 
aThe studies by Wynder et al, 1974; Whittemore et al, 1984; Gamble et al, 1996 analysed the risk of kidney cancer unspecified. bCoh = cohort study;
CCP = Population-based case-control study; CCH = hospital-based case–control study. cM = males; F = females. dRBW1 = actual weight/ideal weight;
RBW2 = actual weight/average weight; BMI = kg m–2. eOnly highest category vs. reference category presented. fRR for men and women unexposed to
hydrocarbon (21 cases). gBoth men and women as reference. hWeight at age 50. 
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